Table 2 Statistically significant cellular pathways identified in pathway analysis of pathogenic variants.
Gene name | Category | Description of Pathway | Adjusted p value |
---|---|---|---|
Affected Cohort | |||
DLAT/MDH2 | Metabolism | Citrate cycle (TCA cycle) | 0.0026 |
Pyruvate metabolism | 0.0055 | ||
Carbon metabolism | 0.0271 | ||
ACADM/ACADSB | Metabolism | Fatty acid degradation | 0.0051 |
Valine, leucine and isoleucine degradation | 0.0055 | ||
Fatty acid metabolism | 0.0072 | ||
Unaffected Cohort | |||
FH/SDHD | Metabolism | Citrate cycle (TCA cycle) | 0.0143 |
CPT2/SDHD/UQCRFS1 | Human Diseases | Diabetic cardiomyopathy | 0.0365 |